Vol. 23/No. 17 | OncologyLive

AI-Powered Focal Therapy Maps Future Treatment Paradigm in Prostate Cancer

September 08, 2022

For clinicians tasked with treating patients with prostate cancer, disease visualization has traditionally consisted of imprecise techniques such as MRI. However, a new artificial intelligence-based approach by Avenda Health is poised to potentially revolutionize the treatment landscape in the field.

Metastatic Breast Cancer Enters a New Era of HER2 Classification

September 02, 2022

A dramatic presentation at the 2022 American Society of Clinical Oncology Annual Meeting changed treatment standards seemingly overnight for women with previously treated metastatic HER2-low breast cancer. However, fundamental questions remain.